Invest in the Future of Diagnostics

RapidTest.AI is uniquely positioned to capture a significant share of the multi-billion dollar at-home testing market by solving the critical "last mile" problem of diagnostic data.

The Investment Opportunity

We are solving a simple problem with a massive impact: self-testing is exploding, but its data stays in the bathroom cabinet. Our technology bridges this gap.

The Problem

Low patient compliance (<5%) in reporting at-home test results leads to missing data, missed diagnoses, and higher downstream costs for healthcare systems.

Our Solution

A patented computer-vision API that reads any rapid test via smartphone, providing clinical-grade results and a secure, automated data push to clinicians.

The Advantage

A scalable SaaS model, assay-agnostic technology, Edge-AI architecture, and a granted USA patent create a strong, defensible market position.

A Vast and Growing Market

Our initial focus on Colorectal Cancer screening is a gateway to the broader diagnostics market.

SAM (USA & Europe)

$1.2-1.7B

Annual potential for CRC screening alone.

At-Home Testing Market

$55.5B

Projected market size by 2033.

AI in Healthcare

31.5% CAGR

The explosive growth rate of our core technological domain.

Traction & Key Milestones

We have a proven track record of execution and a clear roadmap for future growth.

Patented Technology

Granted USA patent with all claims, and multiple continuations submitted. National Phase applications are underway in key territories.

CV Algorithm Developed

Our core computer vision algorithm has been successfully developed and tested according to best V&V practices.

ISO Certified

Certified for ISO 27001 (Information Security) and ISO 13485 (Medical Device Quality Management), ensuring enterprise-readiness.

Strategic Partnerships

Established direct access to leading IVD manufacturers with multiple FDA & CE approved self-tests ready for integration.

Join Us in Shaping the Future

We are seeking partners to help us scale our technology and redefine the landscape of digital health. Contact us to receive our full investor deck and discuss this exciting opportunity.